4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine
C45H46N18O4S — CID 161149400
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine
4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine (PubChem CID 161149400) has the molecular formula C45H46N18O4S and a molecular weight of 935.05 g/mol. Its IUPAC name is 4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine.
Molecular Properties
| Compound Name | 4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine |
|---|---|
| PubChem CID | 161149400 |
| Molecular Formula | C45H46N18O4S |
| Molecular Weight | 935.05 g/mol |
| Exact Mass | 934.37 |
| IUPAC Name | 4-(2-aminoethyl)-N-(pyridin-2-ylmethyl)aniline;2-(furan-2-yl)-5-methylsulfonyl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine;2-(furan-2-yl)-5-N-[2-[4-(pyridin-2-ylmethylamino)phenyl]ethyl]-[1,2,4]triazolo[1,5-a][1,3,5]triazine-5,7-diamine |
| SMILES | CS(=O)(=O)c1nc(N)n2nc(-c3ccco3)nc2n1.NCCc1ccc(NCc2ccccn2)cc1.Nc1nc(NCCc2ccc(NCc3ccccn3)cc2)nc2nc(-c3ccco3)nn12 |
| InChI | InChI=1S/C22H21N9O.C14H17N3.C9H8N6O3S/c23-20-28-21(29-22-27-19(30-31(20)22)18-5-3-13-32-18)25-12-10-15-6-8-16(9-7-15)26-14-17-4-1-2-11-24-17;15-9-8-12-4-6-13(7-5-12)17-11-14-3-1-2-10-16-14;1-19(16,17)9-12-7(10)15-8(13-9)11-6(14-15)5-3-2-4-18-5/h1-9,11,13,26H,10,12,14H2,(H3,23,25,27,28,29,30);1-7,10,17H,8-9,11,15H2;2-4H,1H3,(H2,10,11,12,13,14) |
| InChIKey | UOLYBTGZCNAWDU-UHFFFAOYSA-N |
| XLogP | 4.98 |
| TPSA | 312.29 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 22 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 935.05 |
| LogP ≤ 5 | 4.98 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 22 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 161149400 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.